Cargando…
Statins research unfinished saga: desirability versus feasibility
Drugs in the same class are generally thought to be therapeutically equivalent because of similar mechanisms of action (the so-called "class effect"). However, statins differ in multiple characteristics, including liver and renal metabolism, half-life, effects on several serum lipid compon...
Autores principales: | Fisman, Enrique Z, Adler, Yehuda, Tenenbaum, Alexander |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1156921/ https://www.ncbi.nlm.nih.gov/pubmed/15941471 http://dx.doi.org/10.1186/1475-2840-4-8 |
Ejemplares similares
-
Atherogenic dyslipidemia in metabolic syndrome and type 2 diabetes: therapeutic options beyond statins
por: Tenenbaum, Alexander, et al.
Publicado: (2006) -
Which is the best lipid-modifying strategy in metabolic syndrome and diabetes: fibrates, statins or both?
por: Tenenbaum, Alexander, et al.
Publicado: (2004) -
Women’s midlife health: the unfinished research agenda
por: Harlow, Sioban D., et al.
Publicado: (2023) -
Balanced pan-PPAR activator bezafibrate in combination with statin: comprehensive lipids control and diabetes prevention?
por: Tenenbaum, Alexander, et al.
Publicado: (2012) -
The unfinished war
por: Martelletti, Paolo
Publicado: (2002)